| |
| |
| |
| |
| | | |
|
PR:P13056 | nuclear receptor subfamily 2 group C member 1 (human) | | | | | |
| | | | |
|
PR:000068553 | nuclear receptor subfamily 2 group C member 1 deaminated 1 (human) | | | | | |
| | | | |
|
PR:P13056-1 | nuclear receptor subfamily 2 group C member 1 isoform h1 (human) | | | | | |
| | | | |
|
PR:P13056-2 | nuclear receptor subfamily 2 group C member 1 isoform h2 (human) | | | | | |
| | | | |
|
PR:P13056-3 | nuclear receptor subfamily 2 group C member 1 isoform h3 (human) | | | | | |
| | | | |
|
PR:000071419 | nuclear receptor subfamily 2 group C member 1 phosphorylated 1 (human) | | | | | |
| | | | |
|
PR:000064796 | nuclear receptor subfamily 2 group C member 1 sumoylated 1 (human) | | | | | |
| |
| |
| | | | |
|
PR:P13056 | nuclear receptor subfamily 2 group C member 1 (human) | | | | | |
| | | | | |
|
PR:000068553 | nuclear receptor subfamily 2 group C member 1 deaminated 1 (human) | | | | | |
| | | | | |
|
PR:P13056-1 | nuclear receptor subfamily 2 group C member 1 isoform h1 (human) | | | | | |
| | | | | |
|
PR:P13056-2 | nuclear receptor subfamily 2 group C member 1 isoform h2 (human) | | | | | |
| | | | | |
|
PR:P13056-3 | nuclear receptor subfamily 2 group C member 1 isoform h3 (human) | | | | | |
| | | | | |
|
PR:000071419 | nuclear receptor subfamily 2 group C member 1 phosphorylated 1 (human) | | | | | |
| | | | | |
|
PR:000064796 | nuclear receptor subfamily 2 group C member 1 sumoylated 1 (human) | | | | | |